| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |